Lv4
710 积分 2022-04-09 加入
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
25天前
已完结
IL-17 and IL-17-producing cells in protection versus pathology
25天前
已完结
Immune-mediated inflammatory disease therapeutics: past, present and future
25天前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
25天前
已完结
Immune-mediated inflammatory disease therapeutics: past, present and future
26天前
已完结
Evolutionary-scale prediction of atomic-level protein structure with a language model
2个月前
已完结
Data-driven federated learning in drug discovery with knowledge distillation
2个月前
已完结
Applied Artificial Intelligence for Drug Discovery
2个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
